GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Net Interest Income

Emergent Health (Emergent Health) Net Interest Income : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2007. Start your Free Trial

What is Emergent Health Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Emergent Health's net interest income for the three months ended in . 20 was $0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Emergent Health Net Interest Income Historical Data

The historical data trend for Emergent Health's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent Health Net Interest Income Chart

Emergent Health Annual Data
Trend
Net Interest Income

Emergent Health Quarterly Data
Net Interest Income

Emergent Health Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emergent Health Net Interest Income Related Terms

Thank you for viewing the detailed overview of Emergent Health's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent Health (Emergent Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Net Interest Income
Comparable Companies
BIEI BOM:524516 TSXV:CIP.H BOM:531686 PTXTQ BOM:524606 XCNQ:WRW NSE:PARABDRUGS BOM:533157 INQD XCNQ:CANA BOM:524314 ACCA BOM:511523 BOM:531541 XCNQ:WLLW BKIT BOM:524768 BOM:540359 BOM:524632
Traded in Other Exchanges
N/A
Address
519 8th Avenue, 25th Floor, New York, NY, USA, 10018
Website
https://www.emergenthealthcompany.com
Emergent Health Corp manufactures and sells vitamin products to retail customers across the United States of America.

Emergent Health (Emergent Health) Headlines

From GuruFocus

Emergent's Pending Acquisition "Evolutionary Biologics" Engages "Aesthetics By Design" to Market, Sell and Distribute Regenerative Medicine Products Produced by Evolutionary Biologics with the Initial Focus Being Exo Elixir(TM)

By ACCESSWIRE ACCESSWIRE • 07-26-2022

Emergent Acquires Regen Biowellness, Inc.

By ACCESSWIRE ACCESSWIRE • 08-02-2022

Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB

By ACCESSWIRE ACCESSWIRE • 01-10-2023

Emergent Executes "Letter of Intent" to Acquire Nanosthetic, a Biologics Company That Manufacturers Products to be Sold and Marketed by Evolutionary Biologics

By ACCESSWIRE ACCESSWIRE • 01-26-2023

Emergent Reports Revenues of Approximately $408,000 for the Quarter Ended December 31st, 2022, as Compared to Approximately $185,000 for the Quarter Ended September 30, 2022, an Increase of Over 100%

By ACCESSWIRE ACCESSWIRE • 01-05-2023

Emergent Announces Letter of Intent to Partner with Rallis Co., creator of "Heart Smart Pet" to launch Patented Nutrition based Whipped Cream

By ACCESSWIRE ACCESSWIRE • 12-06-2022

(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company

By ACCESSWIRE ACCESSWIRE • 02-17-2023

Emergent Closing in on Acquisition of Regen Biowellness Regens Bankruptcy Motion to Dismiss Approved Former L'Or�al President Jim Morrison Set to Join Emergents Board of Directors

By ACCESSWIRE ACCESSWIRE • 07-21-2022

Emergent Executes Letter of Intent to Partner with MeetHook to Jointly Develop "Pharmazu Virtual Visits," a Platform for Pet Owners To Have 24/7 Access to Qualified Veterinary Specialists for The USD 119.6 Million Global Veterinary Telehealth Marketplace

By ACCESSWIRE ACCESSWIRE • 11-29-2022

Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics

By ACCESSWIRE ACCESSWIRE • 02-07-2023